Carla Paredes Diaz
Family · Pueblo, CONPI 1932708872
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $773 and has fallen 69.8% since, to $233 in 2025.
Across 85 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$221
- Sanofi Pasteur Inc.$211
- AbbVie$202
- Novo Nordisk$101
- Johnson & Johnson$77
- Sunovion Pharmaceuticals Inc.$74
- plus $708 from 21 others
What the payments were for
- Food & beverage$1,594100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 7 | $221 |
| Sanofi Pasteur Inc. | 7 | $211 |
| AbbVie | 13 | $202 |
| Novo Nordisk | 7 | $101 |
| Johnson & Johnson | 5 | $77 |
| Sunovion Pharmaceuticals Inc. | 5 | $74 |
| Seqirus USA Inc | 4 | $71 |
| Collegium Pharmaceutical, Inc. | 4 | $68 |
| Pfizer | 3 | $52 |
| Merck | 3 | $49 |
| Biohaven Pharmaceuticals, Inc. | 3 | $47 |
| Paratek Pharmaceuticals, Inc. | 3 | $40 |
| Novartis | 2 | $38 |
| Viiv Healthcare Company | 1 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Grifols USA, LLC | 2 | $33 |
| Eisai Inc. | 2 | $32 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Boehringer Ingelheim | 2 | $28 |
| Bayer | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| UCB, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Amgen | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Corium, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$125
How this compares
$1,594 in reported general payments places this provider in the 85th percentile of 2,182 family providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Propranolol Hcl ErPropranolol Hcl | 11 | $101 |
Paid to pharmacies, not to this prescriber.
Other family in Pueblo
- Lisa CloughPueblo$7K
- Tarah SellnerPueblo$6K
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- April RossGrand Junction$95K
- Jeannette LillerColorado Springs$74K
- Teal MeffordThornton$63K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
- Courtney WeirFort Collins$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.